Morning Market Movers
EnteroMedics (NASDAQ: ETRM) moved up 31.39% to $1.80 after the company announced 18 month ReCharge study results.
Conatus Pharmaceuticals (NASDAQ: CNAT) jumped 26.22% to $7.75 as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.